Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

ONCO

OMX
Market closed
Access this stock data via API
Subscribe
Oncopeptides AB
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 31.6M 35.2M 8.4M 118.3M
Cost of revenue 2.7M -1.1M 6K 53.1M
Gross profit 29.0M 36.3M 8.3M 65.2M
Operating expense
Research & development 121.2M 106.9M 217.7M 679.9M
Selling general and admin 197.3M 188.5M 142.2M 873.8M
Other operating expenses -6.0M 1.4M 3.9M
Operating income -284.5M -254.5M -352.1M -1.4B
Non operating interest income
Income 8.2M 8.6M 2.6M 492K
Expense 12.7M 5.8M 883K 948K
Other income expense
Pretax income -284.2M -248.4M -337.7M -1.4B
Tax provision 398K 664K 271K 8.9M
Net income -284.6M -249.1M -338.0M -1.4B
Basic EPS -1.7 -2.0 -2.9 -13.5
Diluted EPS -1.7 -2.0 -2.9 -13.5
Basic average shares 166.4M 126.8M 115.5M 105.7M
Diluted average shares 166.4M 126.8M 115.5M 105.7M
EBITDA -261.8M -231.6M -319.6M -1.4B
Net income from continuing op. -283.5M -253.4M -349.4M -1.4B
Minority interests
Preferred stock dividends 0 0 0 0
Market closed

Exchange is currently closed (non-working day)
Main market opens in 1 day 17 hours 27 minutes

15:32
00:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CEST, UTC+02:00).